Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patients

Yang Da-Wei; Zhang Yong; Hong Qun-Ying; Hu Jie; Li Chun; Pan Bai-Shen; Wang Qun; Ding Fei-Hong; Ou Jia-Xian; Liu Fang-Lei; Zhang Dan; Zhou Jie-Bai; Song Yuan-Lin; Bai Chun-Xue

首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patients

【24h】

Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patients

机译：血清生物标志物检测组在高危人群肺癌早期诊断中的作用

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUNDThis study applied a combined cancer biomarker panel to clinically identify small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) in a high-risk population.

机译：背景这项研究将组合的癌症生物标记物小组应用于临床识别高危人群中的小细胞肺癌（SCLC）和非小细胞肺癌（NSCLC）。

著录项

来源
《Cancer: A Journal of the American Cancer Society》 |2015年第1期|共9页
作者
Yang Da-Wei; Zhang Yong; Hong Qun-Ying; Hu Jie; Li Chun; Pan Bai-Shen; Wang Qun; Ding Fei-Hong; Ou Jia-Xian; Liu Fang-Lei; Zhang Dan; Zhou Jie-Bai; Song Yuan-Lin; Bai Chun-Xue;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
biomarker; delayed diagnosis; non-small cell lung cancer; progastrin-releasing peptide (ProGRP); small cell lung cancer;

机译：生物标志物;延迟诊断;非小细胞肺癌;前胃泌素释放肽（ProGRP）;小细胞肺癌;

相似文献

外文文献
中文文献
专利

1. Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patients [J] . Yang Da-Wei, Zhang Yong, Hong Qun-Ying, Cancer: A Journal of the American Cancer Society . 2015,第17Sepa1a期

机译：血清生物标志物检测组在高危人群肺癌早期诊断中的作用
2. Probability of Cancer in High-Risk Patients Predicted by the Protein-Based Lung Cancer Biomarker Panel in China: LCBP Study [J] . Yang Dawei, Zhang Xiaoju, Powell Charles A., Cancer: A Journal of the American Cancer Society . 2018,第2期

机译：中国蛋白质肺癌生物标志物在中国预测的高风险患者癌症的概率：LCBP研究
3. A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening [J] . BigbeeW.L., GopalakrishnanV., WeissfeldJ.L., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2012,第4期

机译：多重血清生物标志物免疫测定小组可通过CT筛查将临床肺癌患者与发现无癌症的高危人群区分开
4. Machine Learning-powered Prediction of Recurrence in Patients with Non-small Cell Lung Cancer Using Quantitative Clinical and Radiomic Biomarkers [C] . Sehwa Moon, Dahim Choi, Ji-Yeon Lee, Medical Imaging Conference . 2020

机译：使用定量学习和放射生物标志物的机器学习技术预测非小细胞肺癌患者的复发
5. Lung Cancer Screening: Identification of High-Risk Patients and Shared Decision-Making [D] . Formo, Teresa Dianna. 2020

机译：肺癌筛选：鉴定高危患者和共享决策
6. A Multiplexed Serum Biomarker Immunoassay Panel Discriminates Clinical Lung Cancer Patients from High-Risk Individuals Found to be Cancer-Free by CT Screening [O] . William L. Bigbee, Vanathi Gopalakrishnan, Joel L. Weissfeld, -1

机译：多路复用血清生物标志物免疫测定面板歧视来自发现患有抗癌的高危人物的临床肺癌患者通过CT筛选
7. Probability of cancer in high-risk patients predicted by the protein-based lung cancer biomarker panel in China: LCBP study [O] . Dawei Yang, Xiaoju Zhang, Charles A. Powell, 2017

机译：癌症在中国蛋白质肺癌生物标志物群预测的高风险患者中的概率：LCBP研究

Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patients

摘要

著录项

相似文献

相关主题

期刊订阅